This template provides a minimal setup to get React working in Vite with HMR and some ESLint rules.

Relmada Therapeutics Inc. reported its fourth-quarter 2024 earnings, showing a net loss per share of $0.62, an improvement from the previous year’s $0.84 loss per share. The company’s stock ...

Relmada Therapeutics Inc. reported its fourth-quarter 2024 earnings, showing a net loss per share of $0.62, an improvement from the previous year’s $0.84 loss per share. The company’s stock responded ...